Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mach

Showing results (251-260 of 401) with videos related to

Pageof 41
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human NeuroblastomaHwan Lee, Aladdin Riad, Paul Martorano, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 18, 2016
PET imaging of in vivo caspase-3/7 activity following myocardial ischemia-reperfusion injury with the radiolabeled isatin sulfonamide analogue [(18)F]WC-4-116Arun K Thukkani, Kooresh I Shoghi, Dong Zhou, et al.
Annals of Clinical and Translational Neurology|August 13, 2019
Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brainsJinbin Xu, Jianjun Sun, Richard J Perrin, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2017
PARP-1 Expression Quantified by [<sup>18</sup>F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation TherapySamuel Sander Effron, Mehran Makvandi, Lilie Lin, et al.
Organic & Biomolecular Chemistry|May 23, 2014
Development of a PET radiotracer for non-invasive imaging of the reactive oxygen species, superoxide, in vivoWenhua Chu, Andre Chepetan, Dong Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
[ <sup>11</sup> C]Carfentanil PET Whole-Body Imaging of Mu-Opioid Receptors: A First In-Human StudyJacob G Dubroff, Chia-Ju Hsieh, Corinde E Wiers, et al.
Biochemical Pharmacology|March 15, 1995
Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptorS M Efange, R H Mach, C R Smith, et al.
Journal of Medicinal Chemistry|November 11, 2017
Highly Selective Dopamine D<sub>3</sub> Receptor Antagonists with Arylated Diazaspiro Alkane CoresSean W Reilly, Suzy Griffin, Michelle Taylor, et al.
Synapse (New York, N.Y.)|February 23, 2010
[3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamenJinbin Xu, Babak Hassanzadeh, Wenhua Chu, et al.
Nuclear Medicine and Biology|August 24, 2001
Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agentS R Choi, B Yang, K Plössl, et al.
Pageof 41

Showing results (251-260 of 401) with videos related to

Sort By:
Pageof 41
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human NeuroblastomaHwan Lee, Aladdin Riad, Paul Martorano, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 18, 2016
PET imaging of in vivo caspase-3/7 activity following myocardial ischemia-reperfusion injury with the radiolabeled isatin sulfonamide analogue [(18)F]WC-4-116Arun K Thukkani, Kooresh I Shoghi, Dong Zhou, et al.
Annals of Clinical and Translational Neurology|August 13, 2019
Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brainsJinbin Xu, Jianjun Sun, Richard J Perrin, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2017
PARP-1 Expression Quantified by [<sup>18</sup>F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation TherapySamuel Sander Effron, Mehran Makvandi, Lilie Lin, et al.
Organic & Biomolecular Chemistry|May 23, 2014
Development of a PET radiotracer for non-invasive imaging of the reactive oxygen species, superoxide, in vivoWenhua Chu, Andre Chepetan, Dong Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
[ <sup>11</sup> C]Carfentanil PET Whole-Body Imaging of Mu-Opioid Receptors: A First In-Human StudyJacob G Dubroff, Chia-Ju Hsieh, Corinde E Wiers, et al.
Biochemical Pharmacology|March 15, 1995
Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptorS M Efange, R H Mach, C R Smith, et al.
Journal of Medicinal Chemistry|November 11, 2017
Highly Selective Dopamine D<sub>3</sub> Receptor Antagonists with Arylated Diazaspiro Alkane CoresSean W Reilly, Suzy Griffin, Michelle Taylor, et al.
Synapse (New York, N.Y.)|February 23, 2010
[3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamenJinbin Xu, Babak Hassanzadeh, Wenhua Chu, et al.
Nuclear Medicine and Biology|August 24, 2001
Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agentS R Choi, B Yang, K Plössl, et al.
Pageof 41